Dentalcorp Holdings Closes $115-Million Bought Deal

Dentalcorp Holdings Ltd. has closed its previously announced bought deal offering of 7,055,250 subordinate voting shares of the company (including 920,250 subordinate voting shares issued pursuant to the exercise in full of the overallotment option granted by the company to the underwriters (as defined herein)) at a price of $16.30 per subordinate voting share for total gross proceeds to the company of approximately $115-million.

The offering was made through a syndicate of underwriters co-led by CIBC Capital Markets, BMO Capital Markets and TD Securities Inc., and including Jefferies Securities Inc., RBC Capital Markets, Canaccord Genuity Corp., BofA Securities and Scotia Capital Inc.

In connection with the offering, the company and certain institutional shareholders agreed to a lock-up period of 90 days, during which time they will be restricted from disposing of any securities of Dentalcorp without the prior consent of the joint bookrunners, on behalf of the underwriters, subject to certain exemptions.

The offering was completed in Canada by way of a prospectus supplement dated Jan. 14, 2022, to its short form base shelf prospectus dated Jan. 14, 2022, and filed with the securities regulatory authorities in each province and territory of Canada, copies of which are available under the company's profile on SEDAR.

About Dentalcorp Holdings Ltd.

Dentalcorp is Canada's largest and fastest-growing network of dental practices, committed to advancing the overall well-being of Canadians by delivering the best clinical outcomes and unforgettable experiences. Dentalcorp acquires leading dental practices, uniting them in a common goal: to be Canada's most-trusted health care network. Leveraging its industry-leading technology, know-how and scale, Dentalcorp offers professionals the unique opportunity to retain their clinical autonomy while unlocking their potential for future growth.